Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
- PMID: 31860793
- PMCID: PMC7032996
- DOI: 10.1056/NEJMoa1916433
Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI
Abstract
Background: The causative agents for the current national outbreak of electronic-cigarette, or vaping, product use-associated lung injury (EVALI) have not been established. Detection of toxicants in bronchoalveolar-lavage (BAL) fluid from patients with EVALI can provide direct information on exposure within the lung.
Methods: BAL fluids were collected from 51 patients with EVALI in 16 states and from 99 healthy participants who were part of an ongoing study of smoking involving nonsmokers, exclusive users of e-cigarettes or vaping products, and exclusive cigarette smokers that was initiated in 2015. Using the BAL fluid, we performed isotope dilution mass spectrometry to measure several priority toxicants: vitamin E acetate, plant oils, medium-chain triglyceride oil, coconut oil, petroleum distillates, and diluent terpenes.
Results: State and local health departments assigned EVALI case status as confirmed for 25 patients and as probable for 26 patients. Vitamin E acetate was identified in BAL fluid obtained from 48 of 51 case patients (94%) in 16 states but not in such fluid obtained from the healthy comparator group. No other priority toxicants were found in BAL fluid from the case patients or the comparator group, except for coconut oil and limonene, which were found in 1 patient each. Among the case patients for whom laboratory or epidemiologic data were available, 47 of 50 (94%) had detectable tetrahydrocannabinol (THC) or its metabolites in BAL fluid or had reported vaping THC products in the 90 days before the onset of illness. Nicotine or its metabolites were detected in 30 of 47 of the case patients (64%).
Conclusions: Vitamin E acetate was associated with EVALI in a convenience sample of 51 patients in 16 states across the United States. (Funded by the National Cancer Institute and others.).
Copyright © 2019 Massachusetts Medical Society.
Comment in
-
Cornering the Suspects in Vaping-Associated EVALI.N Engl J Med. 2020 Feb 20;382(8):755-756. doi: 10.1056/NEJMe2001065. N Engl J Med. 2020. PMID: 32074424 No abstract available.
Similar articles
-
Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement - Minnesota, 2018 and 2019.MMWR Morb Mortal Wkly Rep. 2019 Nov 29;68(47):1096-1100. doi: 10.15585/mmwr.mm6847e1. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31774740 Free PMC article.
-
Novel methods for the analysis of toxicants in bronchoalveolar lavage fluid samples from e-cigarette, or vaping, product use-associated lung injury cases: Selected petroleum distillates.Rapid Commun Mass Spectrom. 2020 Oct 15;34(19):e8898. doi: 10.1002/rcm.8898. Rapid Commun Mass Spectrom. 2020. PMID: 32672382 Free PMC article.
-
Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, October 2019.MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):985-989. doi: 10.15585/mmwr.mm6843e1. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31671085 Free PMC article.
-
E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs.Crit Rev Toxicol. 2022 Mar;52(3):188-220. doi: 10.1080/10408444.2022.2082918. Epub 2022 Jul 13. Crit Rev Toxicol. 2022. PMID: 35822508 Free PMC article. Review.
-
E-cigarette or vaping product use-associated lung injury.Br J Hosp Med (Lond). 2020 Apr 2;81(4):1-9. doi: 10.12968/hmed.2019.0371. Epub 2020 Apr 8. Br J Hosp Med (Lond). 2020. PMID: 32339005 Review.
Cited by
-
CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury: A Multicenter Cohort of 160 Cases.Chest. 2021 Oct;160(4):1492-1511. doi: 10.1016/j.chest.2021.04.054. Epub 2021 May 3. Chest. 2021. PMID: 33957099 Free PMC article.
-
Longitudinal trajectories of E-cigarette use among adolescents: A 5-year, multiple cohort study of vaping with and without marijuana.Prev Med. 2021 Sep;150:106670. doi: 10.1016/j.ypmed.2021.106670. Epub 2021 Jun 1. Prev Med. 2021. PMID: 34087321 Free PMC article.
-
Association of vaping-related lung injuries with rates of e-cigarette and cannabis use across US states.Addiction. 2021 Mar;116(3):651-657. doi: 10.1111/add.15235. Epub 2020 Sep 28. Addiction. 2021. PMID: 32840932 Free PMC article.
-
E-cigarette or vaping product use associated lung injury, (EVALI) - A diagnosis of exclusion.Respir Med Case Rep. 2020 Jul 25;31:101174. doi: 10.1016/j.rmcr.2020.101174. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32775191 Free PMC article.
-
Chemical Interactions and Cytotoxicity of Terpene and Diluent Vaping Ingredients.Chem Res Toxicol. 2023 Apr 17;36(4):589-597. doi: 10.1021/acs.chemrestox.2c00218. Epub 2022 Oct 24. Chem Res Toxicol. 2023. PMID: 36279315 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Outbreak of lung injury associated with e-cigarette use, or vaping. December 12, 2019. (https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-d...).
-
- Lozier MJ, Wallace B, Anderson K, et al. Update: demographic, product, and sub-stance-use characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injuries — United States, December 2019. MMWR Morb Mortal Wkly Rep 2019;68:1142–8. - PMC - PubMed
-
- Henry TS, Kligerman SJ, Raptis CA, Mann H, Sechrist JW, Kanne JP. Imaging findings of vaping-associated lung injury. AJR Am J Roentgenol 2019. October 8 (Epub ahead of print). - PubMed
-
- Butt YM, Smith ML, Tazelaar HD, et al. Pathology of vaping-associated lung injury. N Engl J Med 2019;381:1780–1. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical